FDA Inspection 1015613 — Zoran Dzamic, MD, PhD
The FDA completed an inspection of Zoran Dzamic, MD, PhD on May 24, 2017 in Belgrade. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Belgrade (Serbia)
Additional details
Clinical Investigator (CI)